Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
2007

Combining Irbesartan and Hydrochlorothiazide for Better Blood Pressure Control

Sample size: 1088 publication Evidence: high

Author Information

Author(s): Flack J M

Primary Institution: Wayne State University and the Detroit Medical Center

Hypothesis

Does the combination of irbesartan and hydrochlorothiazide provide better blood pressure control than either medication alone?

Conclusion

The combination of irbesartan and hydrochlorothiazide is more effective in lowering blood pressure and has a similar side effect profile compared to irbesartan alone.

Supporting Evidence

  • The combination of irbesartan and hydrochlorothiazide significantly reduced blood pressure compared to placebo.
  • 67% of patients achieved normal blood pressure with the combination therapy compared to 29% with placebo.
  • Combination therapy was well tolerated with fewer adverse events compared to monotherapy.

Takeaway

Using two medicines together can help people with high blood pressure get better results than using just one medicine.

Methodology

The study reviewed clinical trials comparing the effects of irbesartan and hydrochlorothiazide on blood pressure in hypertensive patients.

Potential Biases

Potential conflicts of interest due to funding from pharmaceutical companies.

Limitations

The study may not account for all patient demographics and individual responses to treatment.

Participant Demographics

Included hypertensive patients, with a focus on those who are difficult to treat, including elderly and those with diabetes.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1111/j.1742-1241.2007.01577.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication